A New Approach to Managing Schizophrenia Symptoms

A clinical trial has shown that KarXT, a novel schizophrenia treatment, significantly reduces symptoms without relying on traditional dopamine-blocking mechanisms. Offering fewer side effects, this approach could transform care for those with acute psychosis.